As of Mar 03
| -1.84 / -1.53%|
The 24 analysts offering 12-month price forecasts for Celgene have a median target of 140.00, with a high estimate of 163.00 and a low estimate of 74.00. The median estimate represents a +18.17% increase from the last price of 118.47.
The current consensus among 29 polled investment analysts is to Buy stock in Celgene. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.